APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tumor Target Capture Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tumor Target Capture Platform Market Outlook and Growth Opportunities 2026

Report ID 174261010415 April 2026Not stated

Choose your research edition.

Industry ResearchTumor Target Capture Platform Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Target Capture Platform Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tumor Target Capture Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Target Capture Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Tumor Target Capture Platform Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Tumor Target Capture Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor Target Capture Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tumor Target Capture Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tumor Target Capture Platform market include Roche, Guardant Health, Illumina, Bio-Rad, Menarini Silicon Biosystems, GRAIL, Freenome, Angle and Exosome Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Tumor Target Capture Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Target Capture Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Target Capture Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tumor Target Capture Platform market.

Tumor Target Capture Platform Segment by Company

Roche

Guardant Health

Illumina

Bio-Rad

Menarini Silicon Biosystems

GRAIL

Freenome

Angle

Exosome Diagnostics

Nanostring

Cell Microsystems

Vortex Biosciences

MagArray

Qiagen

Adaptive Biotechnologies

Mission Bio

Singleron

BGI

Amoy Diagnostics

GenoSaber

Annoroad

Genecast

Precision Scientific

Tumor Target Capture Platform Segment by Type

Immunoaffinity Capture Platform

Aptamer Capture Platform

Physical Separation Platform

Tumor Target Capture Platform Segment by Application

Clinical Diagnostics Industry

Laboratory Industry

Research and Higher Education Industry

Others

Tumor Target Capture Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tumor Target Capture Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tumor Target Capture Platform key companies, revenue, market share, and recent developments.

3. To split the Tumor Target Capture Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tumor Target Capture Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tumor Target Capture Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Tumor Target Capture Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Target Capture Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Target Capture Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Target Capture Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Target Capture Platform industry.

Chapter 3: Detailed analysis of Tumor Target Capture Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tumor Target Capture Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tumor Target Capture Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tumor Target Capture Platform Industry Trends Table 2. Tumor Target Capture Platform Industry Drivers Table 3. Tumor Target Capture Platform Industry Opportunities and Challenges Table 4. Tumor Target Capture Platform Industry Restraints Table 5. Global Tumor Target Capture Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tumor Target Capture Platform Revenue Share by Company (2021-2026) Table 7. Global Tumor Target Capture Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tumor Target Capture Platform Key Company Manufacturing Base & Headquarters Table 9. Global Tumor Target Capture Platform Company, Product Type & Application Table 10. Global Tumor Target Capture Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tumor Target Capture Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Immunoaffinity Capture Platform Table 15. Significant Companies of Aptamer Capture Platform Table 16. Significant Companies of Physical Separation Platform Table 17. Global Tumor Target Capture Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Tumor Target Capture Platform Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Tumor Target Capture Platform Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Tumor Target Capture Platform Sales Value Share by Type (2021-2026) Table 21. Global Tumor Target Capture Platform Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Clinical Diagnostics Industry Table 23. Significant Companies of Laboratory Industry Table 24. Significant Companies of Research and Higher Education Industry Table 25. Significant Companies of Others Table 26. Global Tumor Target Capture Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tumor Target Capture Platform Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Tumor Target Capture Platform Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Tumor Target Capture Platform Sales Value Share by Application (2021-2026) Table 30. Global Tumor Target Capture Platform Sales Value Share by Application (2027-2032) Table 31. Global Tumor Target Capture Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Tumor Target Capture Platform Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Tumor Target Capture Platform Sales Value Share by Region (2021-2026) Table 34. Global Tumor Target Capture Platform Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Tumor Target Capture Platform Sales Value Share by Region (2027-2032) Table 36. Global Tumor Target Capture Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Tumor Target Capture Platform Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Tumor Target Capture Platform Sales Value Market Share by Country (2021-2026) Table 39. Global Tumor Target Capture Platform Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Tumor Target Capture Platform Sales Value Market Share by Country (2027-2032) Table 41. Roche Company Information Table 42. Roche Business Overview Table 43. Roche Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Roche Tumor Target Capture Platform Product Portfolio Table 45. Roche Recent Development Table 46. Guardant Health Company Information Table 47. Guardant Health Business Overview Table 48. Guardant Health Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Guardant Health Tumor Target Capture Platform Product Portfolio Table 50. Guardant Health Recent Development Table 51. Illumina Company Information Table 52. Illumina Business Overview Table 53. Illumina Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Illumina Tumor Target Capture Platform Product Portfolio Table 55. Illumina Recent Development Table 56. Bio-Rad Company Information Table 57. Bio-Rad Business Overview Table 58. Bio-Rad Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Bio-Rad Tumor Target Capture Platform Product Portfolio Table 60. Bio-Rad Recent Development Table 61. Menarini Silicon Biosystems Company Information Table 62. Menarini Silicon Biosystems Business Overview Table 63. Menarini Silicon Biosystems Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Menarini Silicon Biosystems Tumor Target Capture Platform Product Portfolio Table 65. Menarini Silicon Biosystems Recent Development Table 66. GRAIL Company Information Table 67. GRAIL Business Overview Table 68. GRAIL Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GRAIL Tumor Target Capture Platform Product Portfolio Table 70. GRAIL Recent Development Table 71. Freenome Company Information Table 72. Freenome Business Overview Table 73. Freenome Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Freenome Tumor Target Capture Platform Product Portfolio Table 75. Freenome Recent Development Table 76. Angle Company Information Table 77. Angle Business Overview Table 78. Angle Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Angle Tumor Target Capture Platform Product Portfolio Table 80. Angle Recent Development Table 81. Exosome Diagnostics Company Information Table 82. Exosome Diagnostics Business Overview Table 83. Exosome Diagnostics Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Exosome Diagnostics Tumor Target Capture Platform Product Portfolio Table 85. Exosome Diagnostics Recent Development Table 86. Nanostring Company Information Table 87. Nanostring Business Overview Table 88. Nanostring Tumor Target Capture Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Nanostring Tumor Target Capture Platform Product Portfolio Table 90. Nanostring Recent Development Table 91. Cell Microsystems Company Information Table 92. Cell Microsystems Business Overview Table 93. Cell Microsystems Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Cell Microsystems Tumor Target Capture Platform Product Portfolio Table 95. Cell Microsystems Recent Development Table 96. Vortex Biosciences Company Information Table 97. Vortex Biosciences Business Overview Table 98. Vortex Biosciences Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Vortex Biosciences Tumor Target Capture Platform Product Portfolio Table 100. Vortex Biosciences Recent Development Table 101. MagArray Company Information Table 102. MagArray Business Overview Table 103. MagArray Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. MagArray Tumor Target Capture Platform Product Portfolio Table 105. MagArray Recent Development Table 106. Qiagen Company Information Table 107. Qiagen Business Overview Table 108. Qiagen Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Qiagen Tumor Target Capture Platform Product Portfolio Table 110. Qiagen Recent Development Table 111. Adaptive Biotechnologies Company Information Table 112. Adaptive Biotechnologies Business Overview Table 113. Adaptive Biotechnologies Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Adaptive Biotechnologies Tumor Target Capture Platform Product Portfolio Table 115. Adaptive Biotechnologies Recent Development Table 116. Mission Bio Company Information Table 117. Mission Bio Business Overview Table 118. Mission Bio Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Mission Bio Tumor Target Capture Platform Product Portfolio Table 120. Mission Bio Recent Development Table 121. Singleron Company Information Table 122. Singleron Business Overview Table 123. Singleron Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Singleron Tumor Target Capture Platform Product Portfolio Table 125. Singleron Recent Development Table 126. BGI Company Information Table 127. BGI Business Overview Table 128. BGI Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. BGI Tumor Target Capture Platform Product Portfolio Table 130. BGI Recent Development Table 131. Amoy Diagnostics Company Information Table 132. Amoy Diagnostics Business Overview Table 133. Amoy Diagnostics Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Amoy Diagnostics Tumor Target Capture Platform Product Portfolio Table 135. Amoy Diagnostics Recent Development Table 136. GenoSaber Company Information Table 137. GenoSaber Business Overview Table 138. GenoSaber Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. GenoSaber Tumor Target Capture Platform Product Portfolio Table 140. GenoSaber Recent Development Table 141. Annoroad Company Information Table 142. Annoroad Business Overview Table 143. Annoroad Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Annoroad Tumor Target Capture Platform Product Portfolio Table 145. Annoroad Recent Development Table 146. Genecast Company Information Table 147. Genecast Business Overview Table 148. Genecast Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Genecast Tumor Target Capture Platform Product Portfolio Table 150. Genecast Recent Development Table 151. Precision Scientific Company Information Table 152. Precision Scientific Business Overview Table 153. Precision Scientific Tumor Target Capture Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Precision Scientific Tumor Target Capture Platform Product Portfolio Table 155. Precision Scientific Recent Development Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Tumor Target Capture Platform Product Image Figure 2. Global Tumor Target Capture Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Target Capture Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor Target Capture Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Immunoaffinity Capture Platform Image Figure 8. Aptamer Capture Platform Image Figure 9. Physical Separation Platform Image Figure 10. Global Tumor Target Capture Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Tumor Target Capture Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Tumor Target Capture Platform Sales Value Share by Type (2021-2032) Figure 13. Clinical Diagnostics Industry Image Figure 14. Laboratory Industry Image Figure 15. Research and Higher Education Industry Image Figure 16. Others Image Figure 17. Global Tumor Target Capture Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Tumor Target Capture Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Tumor Target Capture Platform Sales Value Share by Application (2021-2032) Figure 20. Global Tumor Target Capture Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Tumor Target Capture Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Tumor Target Capture Platform Sales Value (2021-2032) & (US$ Million) Figure 23. North America Tumor Target Capture Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Tumor Target Capture Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Tumor Target Capture Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Tumor Target Capture Platform Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Tumor Target Capture Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Tumor Target Capture Platform Sales Value (2021-2032) & (US$ Million) Figure 29. South America Tumor Target Capture Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Tumor Target Capture Platform Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Tumor Target Capture Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Tumor Target Capture Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Immunoaffinity Capture Platform
  • Aptamer Capture Platform
  • Physical Separation Platform
Applications
  • Clinical Diagnostics Industry
  • Laboratory Industry
  • Research and Higher Education Industry
  • Others
Companies covered
  • Roche
  • Guardant Health
  • Illumina
  • Bio-Rad
  • Menarini Silicon Biosystems
  • GRAIL
  • Freenome
  • Angle
  • Exosome Diagnostics
  • Nanostring
  • Cell Microsystems
  • Vortex Biosciences
  • MagArray
  • Qiagen
  • Adaptive Biotechnologies
  • Mission Bio
  • Singleron
  • BGI
  • Amoy Diagnostics
  • GenoSaber
  • Annoroad
  • Genecast
  • Precision Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tumor Target Capture Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tumor Target Capture Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tumor Target Capture Platform Market Dynamics
  1. 2.1 Tumor Target Capture Platform Industry Trends
  2. 2.2 Tumor Target Capture Platform Industry Drivers
  3. 2.3 Tumor Target Capture Platform Industry Opportunities and Challenges
  4. 2.4 Tumor Target Capture Platform Industry Restraints
3 Tumor Target Capture Platform Market by Company
  1. 3.1 Global Tumor Target Capture Platform Company Revenue Ranking in 2025
  2. 3.2 Global Tumor Target Capture Platform Revenue by Company (2021-2026)
  3. 3.3 Global Tumor Target Capture Platform Company Ranking (2024-2026)
  4. 3.4 Global Tumor Target Capture Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Tumor Target Capture Platform Company Product Type and Application
  6. 3.6 Global Tumor Target Capture Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tumor Target Capture Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tumor Target Capture Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tumor Target Capture Platform Market by Type
  1. 4.1 Tumor Target Capture Platform Type Introduction
  2. 4.1.1 Immunoaffinity Capture Platform
  3. 4.1.2 Aptamer Capture Platform
  4. 4.1.3 Physical Separation Platform
  5. 4.2 Global Tumor Target Capture Platform Sales Value by Type
  6. 4.2.1 Global Tumor Target Capture Platform Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tumor Target Capture Platform Sales Value by Type (2021-2032)
  8. 4.2.3 Global Tumor Target Capture Platform Sales Value Share by Type (2021-2032)
5 Tumor Target Capture Platform Market by Application
  1. 5.1 Tumor Target Capture Platform Application Introduction
  2. 5.1.1 Clinical Diagnostics Industry
  3. 5.1.2 Laboratory Industry
  4. 5.1.3 Research and Higher Education Industry
  5. 5.1.4 Others
  6. 5.2 Global Tumor Target Capture Platform Sales Value by Application
  7. 5.2.1 Global Tumor Target Capture Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tumor Target Capture Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Tumor Target Capture Platform Sales Value Share by Application (2021-2032)
6 Tumor Target Capture Platform Regional Value Analysis
  1. 6.1 Global Tumor Target Capture Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor Target Capture Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tumor Target Capture Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tumor Target Capture Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tumor Target Capture Platform Sales Value (2021-2032)
  7. 6.3.2 North America Tumor Target Capture Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tumor Target Capture Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Tumor Target Capture Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tumor Target Capture Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tumor Target Capture Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tumor Target Capture Platform Sales Value (2021-2032)
  16. 6.6.2 South America Tumor Target Capture Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tumor Target Capture Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tumor Target Capture Platform Sales Value Share by Country, 2025 VS 2032
7 Tumor Target Capture Platform Country-level Value Analysis
  1. 7.1 Global Tumor Target Capture Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tumor Target Capture Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tumor Target Capture Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tumor Target Capture Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tumor Target Capture Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tumor Target Capture Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tumor Target Capture Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Tumor Target Capture Platform Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Guardant Health
  8. 8.2.1 Guardant Health Company Information
  9. 8.2.2 Guardant Health Business Overview
  10. 8.2.3 Guardant Health Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guardant Health Tumor Target Capture Platform Product Portfolio
  12. 8.2.5 Guardant Health Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Tumor Target Capture Platform Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 Bio-Rad
  20. 8.4.1 Bio-Rad Company Information
  21. 8.4.2 Bio-Rad Business Overview
  22. 8.4.3 Bio-Rad Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad Tumor Target Capture Platform Product Portfolio
  24. 8.4.5 Bio-Rad Recent Developments
  25. 8.5 Menarini Silicon Biosystems
  26. 8.5.1 Menarini Silicon Biosystems Company Information
  27. 8.5.2 Menarini Silicon Biosystems Business Overview
  28. 8.5.3 Menarini Silicon Biosystems Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Menarini Silicon Biosystems Tumor Target Capture Platform Product Portfolio
  30. 8.5.5 Menarini Silicon Biosystems Recent Developments
  31. 8.6 GRAIL
  32. 8.6.1 GRAIL Company Information
  33. 8.6.2 GRAIL Business Overview
  34. 8.6.3 GRAIL Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GRAIL Tumor Target Capture Platform Product Portfolio
  36. 8.6.5 GRAIL Recent Developments
  37. 8.7 Freenome
  38. 8.7.1 Freenome Company Information
  39. 8.7.2 Freenome Business Overview
  40. 8.7.3 Freenome Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Freenome Tumor Target Capture Platform Product Portfolio
  42. 8.7.5 Freenome Recent Developments
  43. 8.8 Angle
  44. 8.8.1 Angle Company Information
  45. 8.8.2 Angle Business Overview
  46. 8.8.3 Angle Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Angle Tumor Target Capture Platform Product Portfolio
  48. 8.8.5 Angle Recent Developments
  49. 8.9 Exosome Diagnostics
  50. 8.9.1 Exosome Diagnostics Company Information
  51. 8.9.2 Exosome Diagnostics Business Overview
  52. 8.9.3 Exosome Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Exosome Diagnostics Tumor Target Capture Platform Product Portfolio
  54. 8.9.5 Exosome Diagnostics Recent Developments
  55. 8.10 Nanostring
  56. 8.10.1 Nanostring Company Information
  57. 8.10.2 Nanostring Business Overview
  58. 8.10.3 Nanostring Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanostring Tumor Target Capture Platform Product Portfolio
  60. 8.10.5 Nanostring Recent Developments
  61. 8.11 Cell Microsystems
  62. 8.11.1 Cell Microsystems Company Information
  63. 8.11.2 Cell Microsystems Business Overview
  64. 8.11.3 Cell Microsystems Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cell Microsystems Tumor Target Capture Platform Product Portfolio
  66. 8.11.5 Cell Microsystems Recent Developments
  67. 8.12 Vortex Biosciences
  68. 8.12.1 Vortex Biosciences Company Information
  69. 8.12.2 Vortex Biosciences Business Overview
  70. 8.12.3 Vortex Biosciences Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vortex Biosciences Tumor Target Capture Platform Product Portfolio
  72. 8.12.5 Vortex Biosciences Recent Developments
  73. 8.13 MagArray
  74. 8.13.1 MagArray Company Information
  75. 8.13.2 MagArray Business Overview
  76. 8.13.3 MagArray Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MagArray Tumor Target Capture Platform Product Portfolio
  78. 8.13.5 MagArray Recent Developments
  79. 8.14 Qiagen
  80. 8.14.1 Qiagen Company Information
  81. 8.14.2 Qiagen Business Overview
  82. 8.14.3 Qiagen Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Qiagen Tumor Target Capture Platform Product Portfolio
  84. 8.14.5 Qiagen Recent Developments
  85. 8.15 Adaptive Biotechnologies
  86. 8.15.1 Adaptive Biotechnologies Company Information
  87. 8.15.2 Adaptive Biotechnologies Business Overview
  88. 8.15.3 Adaptive Biotechnologies Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Adaptive Biotechnologies Tumor Target Capture Platform Product Portfolio
  90. 8.15.5 Adaptive Biotechnologies Recent Developments
  91. 8.16 Mission Bio
  92. 8.16.1 Mission Bio Company Information
  93. 8.16.2 Mission Bio Business Overview
  94. 8.16.3 Mission Bio Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Mission Bio Tumor Target Capture Platform Product Portfolio
  96. 8.16.5 Mission Bio Recent Developments
  97. 8.17 Singleron
  98. 8.17.1 Singleron Company Information
  99. 8.17.2 Singleron Business Overview
  100. 8.17.3 Singleron Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Singleron Tumor Target Capture Platform Product Portfolio
  102. 8.17.5 Singleron Recent Developments
  103. 8.18 BGI
  104. 8.18.1 BGI Company Information
  105. 8.18.2 BGI Business Overview
  106. 8.18.3 BGI Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BGI Tumor Target Capture Platform Product Portfolio
  108. 8.18.5 BGI Recent Developments
  109. 8.19 Amoy Diagnostics
  110. 8.19.1 Amoy Diagnostics Company Information
  111. 8.19.2 Amoy Diagnostics Business Overview
  112. 8.19.3 Amoy Diagnostics Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Amoy Diagnostics Tumor Target Capture Platform Product Portfolio
  114. 8.19.5 Amoy Diagnostics Recent Developments
  115. 8.20 GenoSaber
  116. 8.20.1 GenoSaber Company Information
  117. 8.20.2 GenoSaber Business Overview
  118. 8.20.3 GenoSaber Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  119. 8.20.4 GenoSaber Tumor Target Capture Platform Product Portfolio
  120. 8.20.5 GenoSaber Recent Developments
  121. 8.21 Annoroad
  122. 8.21.1 Annoroad Company Information
  123. 8.21.2 Annoroad Business Overview
  124. 8.21.3 Annoroad Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Annoroad Tumor Target Capture Platform Product Portfolio
  126. 8.21.5 Annoroad Recent Developments
  127. 8.22 Genecast
  128. 8.22.1 Genecast Company Information
  129. 8.22.2 Genecast Business Overview
  130. 8.22.3 Genecast Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Genecast Tumor Target Capture Platform Product Portfolio
  132. 8.22.5 Genecast Recent Developments
  133. 8.23 Precision Scientific
  134. 8.23.1 Precision Scientific Company Information
  135. 8.23.2 Precision Scientific Business Overview
  136. 8.23.3 Precision Scientific Tumor Target Capture Platform Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Precision Scientific Tumor Target Capture Platform Product Portfolio
  138. 8.23.5 Precision Scientific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst